Answers are grounded in this paper and cite their sources.
Trialkylation of 1-amino-1-carba- closo -dodecaborane with 1-bromo-3,3-bis(2-bromoethyl)octane affords 1-(4-pentylquinuclidin-1-yl)-1-carba- closo -dodecaborane in 29% yield which can then be iodinated to form title compound 1 in 40% yield. The molecular and crystal structure of 1 has been determined by X-ray crystallography [C 13 H 33 B 11 IN, monoclinic P 2 1 / c: a = 10.3405(2) Å, b = 16.4404(1) Å, c = 12.7223(2) Å, β = 100.156(1)°, Z = 4]. The structural features of 1 are compared with those in analogous compounds. The B−I bond length (2.196(6) Å) is an intermediate value between those found in neutral iodocarboranes and charged B 12 H 11 I(−2). NMR data is correlated with the structure of 1 and the additivity of NR 3 and halogen substituent effects is tested.
No takes yet. Share an insight, caveat, or question.
Douglass et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: